Adjust gabapentin dose to avoid respiratory depression, MHRA advises

Prescribers may need to adjust the dose of gabapentin in patients at risk of respiratory depression, including those taking CNS depressants and elderly people.

Dose adjustments in gabapentin may be necessary in patients who are at higher risk of respiratory depression. | VICTOR DE SCHWANBERG/SCIENCE PHOTO LIBRARY
Dose adjustments in gabapentin may be necessary in patients who are at higher risk of respiratory depression. | VICTOR DE SCHWANBERG/SCIENCE PHOTO LIBRARY

Gabapentin (Neurontin) has been associated with a rare risk of severe respiratory depression when prescribed with or without concomitant opioids.

Prescribers should consider whether the dose of gabapentin needs to be adjusted in patients at higher risk of respiratory depression, including patients with compromised respiratory function, those with respiratory or neurological disease or renal impairment, patients taking other CNS depressants and elderly people.

When prescribing gabapentin in patients with epilepsy or neuropathic pain who require concomitant treatment with opioid medicines, prescribers should carefully monitor for signs of CNS depression, such as somnolence, sedation, and respiratory depression, and reduce the dose of either gabapentin or the opioid as appropriate.

Want news like this straight to your inbox?
Sign up for our bulletins

Chloe Harman recommends

Epilepsy prescribing notes

Read more

Have you registered with us yet?

Register now to enjoy more articles and free email bulletins

Register
Already registered?
Sign in

Register or Subscribe to MIMS

GPs can get MIMS print & online and GPonline for free when they register online – take 2 minutes, and make sure you get your free MIMS access! If you're not a GP, you can subscribe to MIMS for full access.

Register or subscribe

MIMS Dermatology

Read the latest issue online exclusively on MIMS Learning.

Read MIMS Dermatology

MIMS Adviser

Especially created for prescribing influencers.

Request free copy

Mobile apps

MIMS: access the full drug database and quick-reference tables on the go

MIMS Diagnosis and Management: concise information on signs and symptoms, investigations and diseases